ANGPTL3 and diabetic kidney disease: Moreover, adjunctive therapy with anti-ANGPTL3 antibodies or the absence of ANGPTL3 significantly alleviates podocyte injury in DKD mouse models (Ma Q. et al., 2022; Ma et al., 2023c).